Skip to content

How do seniors afford HUMIRA? A comprehensive guide to financial assistance

According to the Department of Health and Human Services, HUMIRA is among the most expensive drugs covered by Medicare Part D. Despite its high cost, numerous avenues exist to help seniors afford HUMIRA, from manufacturer programs to government subsidies and new Medicare benefits.

Quick Summary

Seniors can afford HUMIRA through several financial programs, including Medicare Part D, the manufacturer-sponsored myAbbVie Assist, biosimilar alternatives, and federal subsidies like Medicare Extra Help, all of which can significantly reduce or eliminate out-of-pocket costs.

Key Points

  • Medicare Updates 2025: The Inflation Reduction Act caps annual out-of-pocket prescription costs for Part D enrollees at $2,000, significantly reducing the financial burden for seniors.

  • Manufacturer Patient Assistance: The myAbbVie Assist program can provide free HUMIRA to eligible, low-income seniors who are uninsured or underinsured.

  • Medicare Extra Help: Low-income seniors can receive substantial subsidies on Part D costs through the Extra Help program, with capped copayments for covered drugs.

  • Consider Biosimilars: Lower-cost biosimilar versions of HUMIRA (adalimumab) are available and may be a medically appropriate and affordable alternative, as determined by a doctor.

  • Utilize Charitable Foundations: Independent non-profit organizations offer grants to help cover copayments, deductibles, and other out-of-pocket expenses for seniors with chronic conditions.

  • Explore Payment Plans: Medicare's new Prescription Payment Plan allows seniors to manage their yearly drug costs by spreading payments across the year.

In This Article

Understanding HUMIRA Costs and Senior Challenges

Managing the high cost of a specialty medication like HUMIRA is a major concern for many seniors living with conditions such as rheumatoid arthritis, Crohn's disease, or psoriasis. The list price can be prohibitive, making a reliable and predictable plan for covering expenses essential for continued treatment.

The Impact of the 2025 Medicare Changes

Significant changes introduced in 2025 by the Inflation Reduction Act have greatly benefited Medicare Part D enrollees. The most impactful change is the $2,000 annual cap on out-of-pocket prescription drug costs. Once a senior's spending reaches this limit, their covered medications are paid for in full by their Part D plan for the rest of the year. Additionally, a new Medicare Prescription Payment Plan (MPPP) allows seniors to spread their out-of-pocket costs into more manageable monthly payments.

Manufacturer and Program-Based Assistance

Beyond government programs, several avenues exist to help seniors reduce their HUMIRA expenses. Exploring these resources can offer substantial relief.

The myAbbVie Assist Patient Assistance Program

AbbVie, the manufacturer of HUMIRA, offers a patient assistance program called myAbbVie Assist for those who are uninsured or underinsured and meet certain income criteria. This program can provide qualifying patients with their medication for free, with no copayments or shipping costs. The application process can be initiated by calling the company or applying online.

Savings Cards and Rebates

While the HUMIRA Complete Savings Card is not available to seniors with Medicare or other government-funded insurance programs, some seniors may be eligible for prescription rebates. It is crucial to contact a HUMIRA Complete insurance specialist to understand all available savings options for your specific situation.

Independent Charitable Foundations

Several non-profit organizations offer assistance to help patients with chronic illnesses afford their medications. These programs can provide grants for copays, deductibles, and other expenses. Examples include The Assistance Fund and the Patient Advocate Foundation, which can be found via resources like NeedyMeds.

Government-Sponsored Financial Aid

Federal and state programs provide a critical safety net for seniors with limited income and resources, ensuring access to necessary medications.

Medicare Extra Help (Low-Income Subsidy)

For low-income seniors enrolled in Medicare Part D, Extra Help can significantly reduce prescription drug costs, including premiums and deductibles. For 2025, beneficiaries with Extra Help will pay no more than $4.90 for a covered generic drug and $12.15 for a covered brand-name drug like HUMIRA. Eligibility is determined based on income and resources, and those with Medicaid or Supplemental Security Income (SSI) qualify automatically.

Medicaid and PACE Programs

Medicaid, a federal-state program for low-income individuals and families, may cover the cost of HUMIRA, though coverage details vary by state. The Program of All-Inclusive Care for the Elderly (PACE) is another option that can assist with medication costs for eligible seniors who need a high level of care but wish to remain in their community.

Optimizing Medicare for HUMIRA Coverage

Choosing the right Medicare plan can make a substantial difference in out-of-pocket costs for HUMIRA, often designated as a high-tier specialty drug.

Part D vs. Part C (Medicare Advantage)

HUMIRA coverage typically falls under a Medicare Part D prescription drug plan if it is self-administered at home. If administered in a doctor's office or clinic, it may be covered under Medicare Part B. Medicare Advantage (Part C) plans often include prescription drug coverage, so it is essential to review the specific plan's formulary.

Comparing Plan Formularies and Tiers

When selecting a plan during the annual enrollment period, seniors should use the Medicare plan comparison tool to check which plans cover HUMIRA and where it falls on the formulary. HUMIRA is often a specialty tier drug with higher cost-sharing, making careful comparison vital. Since Medicare requires coverage of certain drug categories, plans may offer a biosimilar alternative with a lower copay.

Exploring Treatment Alternatives

Discussion with a healthcare provider about potential alternatives can be a crucial step toward managing costs.

Biosimilar Options

With the introduction of biosimilars for HUMIRA (adalimumab), seniors have more affordable treatment options. While biosimilars are not generic drugs, they are highly similar to and just as effective as the original biologic. A doctor and pharmacist can advise if a biosimilar is a suitable and lower-cost option for your specific condition.

Leveraging Your Healthcare Team and Pharmacy

Your healthcare provider and pharmacist can be powerful advocates in helping to reduce HUMIRA costs. They can provide samples, help with appeals, and offer guidance on navigating assistance programs.

Doctor's Office Support

Healthcare professionals can assist with the application process for patient assistance programs and help navigate prior authorization requirements often mandated by insurance companies. They may also have access to free samples to help you get started with treatment.

Pharmacy Resources

Pharmacists can provide valuable information on network discounts and alternative savings programs, such as mail-order pharmacies, which can sometimes offer lower prices for a 90-day supply.

Comparing Financial Assistance Options

To illustrate the different avenues available, here is a comparison table outlining potential assistance options for seniors needing HUMIRA.

Program/Option Best For Potential Savings Requirements Notes
myAbbVie Assist Uninsured or underinsured seniors with low income Free medication Specific income and insurance status criteria Directly from the manufacturer
Medicare Extra Help Low-income seniors enrolled in Medicare Part D Significantly reduced copays ($12.15 brand cap for 2025) Income and resource limits Automatic for some; requires application otherwise
Medicaid Low-income individuals, varying by state Varies by state; may offer low or no copay Varies by state State-run program; may have eligibility overlap with Extra Help
Biosimilar Alternatives All seniors looking for cost-effective options Potentially significant savings over brand HUMIRA Discuss with healthcare provider Not a generic, but highly similar and cheaper
Independent Foundations Underinsured patients needing copay relief Variable; can cover copays, deductibles Vary by foundation (income, condition) Good for covering out-of-pocket costs not covered by insurance
Medicare Prescription Payment Plan Seniors needing to budget large drug costs Spreads out-of-pocket spending over the year Must be enrolled in a Part D plan Doesn't reduce total cost, but helps cash flow

Conclusion

Affording HUMIRA as a senior, while challenging due to its high cost, is achievable by utilizing a combination of available resources. The 2025 Medicare out-of-pocket cap and payment plan options provide a new layer of protection for all enrollees. Seniors with limited income should prioritize applying for Medicare Extra Help and exploring the manufacturer's myAbbVie Assist program. Additionally, discussing biosimilars with a doctor and seeking grants from independent foundations can provide further financial relief. By proactively navigating these programs, seniors can manage their expenses and continue their critical treatment without undue financial stress. A valuable starting point is to connect with an insurance specialist through the HUMIRA Complete program to get tailored advice and resources.

Frequently Asked Questions

Starting in 2025, the annual out-of-pocket spending cap for covered Part D drugs, including HUMIRA, is set at $2,000. Additionally, the Medicare Prescription Payment Plan allows you to pay your out-of-pocket costs in more manageable monthly installments instead of all at once.

No, the myAbbVie Assist patient assistance program is generally for uninsured or underinsured patients who meet specific income requirements. Those enrolled in Medicare or other government-funded programs are typically not eligible for this specific program.

You can apply for Medicare's Extra Help (Low-Income Subsidy) through the Social Security Administration website or by calling them. Eligibility depends on your income and resources. Those on Medicaid or Supplemental Security Income (SSI) often qualify automatically.

A biosimilar is a biologic medicine that is highly similar to an FDA-approved reference product, like HUMIRA, and is typically a more affordable option. Several HUMIRA biosimilars are available, and your doctor can determine if one is an appropriate and more cost-effective alternative for you.

Many Medicare Advantage plans include prescription drug coverage (Part D), which may cover HUMIRA. You will need to check your plan's specific formulary to confirm if it is covered and what your out-of-pocket costs will be, as this can vary by plan.

Yes, many independent charitable foundations, such as the Patient Advocate Foundation and The Assistance Fund, offer grants to help qualified patients with their out-of-pocket costs, including copayments and deductibles. Resources like NeedyMeds can help you find them.

If your plan denies coverage, your doctor can submit a prior authorization request or file an appeal on your behalf. Additionally, you may still qualify for the manufacturer's patient assistance program if you are considered underinsured.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.